Investors
Keep up to date on investor-related events and information.
Full-year financial statement for 2025
Our financial results for the full-year 2025 were announced on February 25, 2026.
Read the company announcement
Download the conference call slides
Download the roadshow presentation
Annual General Meeting 2026
The Board of Directors is pleased to invite you to the Annual General Meeting 2026 of Novonesis (Novozymes A/S) to be held on March 23, 2026, at 4:00 pm CET.
The Annual General Meeting will be held at Gammel Venlighedsvej 14, DK-2970 Hoersholm. There will also be access to the meeting from the entrance at Boege Alle 10-12, DK-2970 Hoersholm.
9M 2025 interim report
Our interim report for the first nine months was released on November 6, 2025.
Read the company announcement
Download the conference call slidesH1 results call included 2030 strategy update
On August 21, Novonesis held an extended conference call in connection with the H1 results release where the updated 2030 strategy and financial targets were also presented.
H1 financial results
Read the company announcement
Download the conference call slides2030 strategy update
Read the company announcement
Download the conference call slidesQ1 2025 interim report
Our interim report for the first quarter was released on May 8, 2025.
Read the company announcement
Download the conference call slides
Download the roadshow presentationFull-year financial statement for 2024
Novonesis released full-year results on February 26, 2025.
Read the company announcement
Download the conference call slides
Download the roadshow presentationNovonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
Novonesis hosted a conference call on the acquisition on February 11, 2025.
Read the company announcement
Download the conference call slides
Contact investor relations
We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novonesis.